MINSK, 24 August (BelTA) – The Belarusian Healthcare Ministry and the South Korean company LG Chem Ltd will exchange information in the course of investigation of a child death in Gantsevichi District, Brest Oblast. The relevant agreement was reached at a meeting with LG Chem Ltd representatives at premises of the Belarusian Healthcare Ministry, the ministry's press service told BelTA.
According to the source, LG Chem Ltd vowed to do everything to investigate the case, in which serious complications led to the death, and enable interaction between the company and the national pharmaceutical oversight system.
LG Chem Ltd representatives were informed about the tragedy in Gantsevichi District and progress in the investigation. The child had been injected with a Eupenta vaccine made by LG Chem Ltd and an Imovax Polio vaccine made by the French company Sanofi Pasteur. The authorized representative of the South Korean company expressed deep regret about the tragedy. He noted the tragedy cannot be neglected. The quality of the vaccine had been checked in labs in Switzerland, Italy, and Belgium within the framework of cooperation with the World Health Organization and the company had had no complaints from other countries. Over 50 million vaccine doses have been used all over the world since the product became available.
Since the child in Gantsevichi District developed fatal complications after being injected with two different vaccines, both Eupenta and Imovax Polio are now investigated. Their use has been suspended.
